Clinical Trial: A Study to Evaluate YF087 in Subjects With MSI-H or dMMR Advanced Solid Tumors

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809607) titled 'A Study to Evaluate YF087 in Subjects With MSI-H or dMMR Advanced Solid Tumors' on Aug. 30.

Brief Summary: This is an open-label, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of YF087 in subjects with Microsatellite Instability-High (MSI-H) or Mismatch Repair-Deficient (dMMR) advanced solid tumors.

Study Start Date: Sept. 18

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor Cancer

Intervention: DRUG: YF087

Dosage form: Tablet * Administration route: Oral, once a day

Recruitment Status: NOT_YET_RECRUITING

Sponsor: InventisBio Co., Ltd

Disclaimer: Curated by HT Syndication....